BUY Cipla Ltd. — Rajesh Palviya, Axis Securities
byRajesh Palviya, Axis SecuritiesHorizon: NA (inferred Swing (≤2wk))29 Sept 2026via ET Now (Live)
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
Wockhardt Share Price Today: 2.19% rise and sector view
NewsGoogle News·17 Sept · 2w ago
1 advisor has an active short-term BUY call on this stock
Advisor consensus · adjacent horizon·7 Jul · 3mo ago
ICICI Lombard, United Breweries And Cipla: Three Stocks That Bucked The Trend As Stock Market Crashed
NewsNdtv-Profit·24 Sept · 6d ago
Anthem Biosciences Share Price Today: valuation and peers
NewsGoogle News·18 Sept · 2w ago
SYMBIOTEC Share Price News: price rise and valuation view
NewsGoogle News·18 Sept · 2w ago
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Cipla
- BUY — Arun Kumar Mantri13 Nov 2026 · Same day · target ₹1,450 · Expired
- BUY — Rajesh Satpute8 Nov 2026 · Next day · target ₹1,440 · Expired
- BUY — Prakash Gaba4 Nov 2026 · Same day · target ₹1,410 · Expired
- BUY — Kush Bohra3 Nov 2026 · Same day · target ₹1,415 · Expired
- BUY — Rakesh Bansal2 Nov 2026 · Same day · target ₹1,407 · Expired
More from Rajesh Palviya, Axis Securities
- BUY Kotak Mahindra Bank26 Oct 2026 · Same day · target ₹455 · Expired
- BUY Sansera Engineering8 Oct 2026 · ~2 weeks · target ₹4,350 · SL hit
- BUY Trent8 Oct 2026 · ~2 weeks · target ₹3,050 · SL hit
- SELL Sun Pharmaceutical Industries5 Oct 2026 · ~3 months · target ₹1,720 · SL hit
- BUY Zydus Lifesciences29 Sept 2026 · ~2 weeks · target ₹1,280 · SL hit

